ABCC1 and endothelial dysfunction: Taken together, ABCC1 might contribute to the onset and progression of CVD, and ABCC1 inhibition may represent a novel strategy to prevent hypertension, endothelial dysfunction and atherosclerotic vascular disease in high-risk cardiovascular patients.